The Dangers of Heart Failure Associated with Onglyza
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm.
When Onglyza (saxagliptin) arrived on the marker in 2009, it was seen as a new frontier in maintaining blood sugar levels in type 2 diabetics. The excitement faded when the drug was linked to heart failure and other serious complications.
These aren’t typical side effects – they are life-threatening conditions that require extensive and costly medical treatment. If you or a loved one has suffered due to Onglyza, you should speak with an attorney about your options. Hiring an attorney to seek compensation may be the best way to get the help you need.
The Michael Brady Lynch Firm offers case evaluations at no cost or obligation to you. You should call us today at (877) 513-9517 or contact us online to learn more about what we can do to help you and your family.
Onglyza Increases Risk of Heart Failure
In February of 2014, the Food and Drug Administration warned that Onglyza may be linked to an increased risk of heart failure. The FDA cited the findings of a study published in the New England Journal of Medicine as a cause for concern.
In that study, researchers examined more than 16,000 people and found that those taking Onglyza were 27% more likely to be hospitalized for heart failure than those who did not take the drug.
Heart failure is a potentially deadly condition that arises when the heart does not pump blood thoroughly enough to satisfy the needs of the body. According to the Centers for Disease Control and Prevention, heart failure contributed to 1 in every 9 deaths in the U.S. in 2009. Half of all people who develop heart failure will die within 5 years of the diagnosis, according to the CDC.
Signs and symptoms of heart failure include:
Shortness of breath/difficulty breathing
Swelling in the feet, legs, arms or stomach
Feeling tired or weak
FDA Finds Possible Link to Pancreatic Cancer
In April 2013, the FDA warned that Onglyza and similar drugs may increase the risk of pancreatitis. The drug may be linked to the development of pre-cancerous tissue in the pancreas. The agency urged further investigation.
Pancreatitis and pancreatic cancer have the following symptoms:
Sudden weight loss
About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects including Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, Xarelto bleeding injuries, Mirena IUD, Actos Bladder Cancer, Invokana ketoacidosis, Testosterone heart attack and stroke injuries and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.